Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0750
-0.0080 (-9.64%)
Jul 7, 2026, 3:33 PM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 87.28 million as of July 6, 2026. Its market cap has increased by 130.58% in one year.
Market Cap
87.28M
Enterprise Value
77.78M
Revenue
4.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 87.28M, an increase of 1,424.59%. That is a compound annual growth rate of 10.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 87.28M | -1.19% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 91.95M |
| Avecho Biotechnology | 88.10M |
| Immutep | 81.05M |
| Arovella Therapeutics | 79.78M |
| Amplia Therapeutics | 77.00M |
| Radiopharm Theranostics | 70.88M |
| Nexsen | 61.06M |
| Botanix Pharmaceuticals | 57.42M |